Synthesis of the Enantiomer of 1alfa,25-Dihydroxy Vitamin D3(calcitrol) and a Diastereomer of 1alfa,25-Dihydroxy Vitamin D3, Differing from Natural Product in Configuratoion at All but One Asymmetric Carbon Atoms

Achmatowicz, B.; Przezdziecka, A.; Wicha, J.

Artykuł - szczegóły

Tytuł artykułu

Synthesis of the Enantiomer of 1alfa,25-Dihydroxy Vitamin D3(calcitrol) and a Diastereomer of 1alfa,25-Dihydroxy Vitamin D3, Differing from Natural Product in Configuratoion at All but One Asymmetric Carbon Atoms

Autorzy

Achmatowicz B. , Przezdziecka A. , Wicha J.

Identyfikatory

Warianty tytułu

Języki publikacji

Abstrakty

Convergent synthesis of ent-1alfa,25-dihydroxyvitamin D3 (ent-calcitriol, 2) and (1S,3S, 13S,14S,17S,20S) - 1alfa,25-dihydroxyvitamin D3 (5) using the ring A building blocks, 6 and 7, respectively, and rings CD building block8, is described. Building block 6 was obtained starting from vitamin D3 via dihydroxylation of the C7-C8 double bond, Mitsunobu inversion at C3, diastereoselective hydroxylation at C1 and cleavage of the C7-C8 bond. Building block 7 was prepared from known synthetic intermediate, 16a(1R,3S) via benzylation of the primary hydroxy group, mono-deprotection of bis-silyl ether 16b and Mitsunobu inversion of the configuration at C3 in 19. Synthetic building blocks were combined using Julia-Kocienski olefination reaction. Key words:Vitamins D, convergent synthesis, Mitsunobu reaction, olefination reaction

Słowa kluczowe

vitamins D convergent synthesis Mitsunobu reaction

Wydawca

Polskie Towarzystwo Chemiczne

Czasopismo

Polish Journal of Chemistry

Rocznik

2005

Tom

Vol. 79 / nr 2

Strony

413--428

Opis fizyczny

Bibliogr. poz. 40

Twórcy

autor

Achmatowicz B.

Institute of Organic Chemistry, Polish Academy of Sciences, ul. Kasprzaka 44/52, 01-224 Warszawa 42, Poland

autor

Przezdziecka A.

Institute of Organic Chemistry, Polish Academy of Sciences, ul. Kasprzaka 44/52, 01-224 Warszawa 42, Poland

autor

Wicha J.

Institute of Organic Chemistry, Polish Academy of Sciences, ul. Kasprzaka 44/52, 01-224 Warszawa 42, Poland

Bibliografia

1. Bouillon R., Okamura W.H. and Norman A.W., Endoc. Rev., 16, 200 (1995).
2. Beckman M.J. and DeLuca H.F., in Progr: Med Chem., WI. 35 (Eds; G.P. Ellis, D.K. Luseombe, A.W. Oxford), Elsevier, Amsterdam, pp. 1, (1998).
3. Posner G.H. and Kaluarnan M., Eur. .J. Org. Chem, 3889 (2003).
4. Kabat M.M. and Radinov R., Curr: Opin. Drug Discovery Dev., 4, 808 (2001).
5.Nonnan A.W., Nemere I., Zhou L.X., Bishop J.E., Lowe K.E., Maiyer A.C., Collins E.D., Taoka T., Sergeev I. and Farach-Carson M.C., .J Steroid Biochem. Molec. Biol., 41, 231 (1992).
6. Binderup L., Latini S., Binderup E., Bertting C., Calverley M. and Hansen K., Biochem. Pharmacol. , 42, 1569 ( 1991).
7. DeLuca H.F. and Wicha J., US. Patent 5,552,392 (1996; Appl. Non 3, 1993).
8. Kurek-Tyrlik A., Makaev F.Z., Wicha J . and Calverley M.J., Liebigs Ann./Recueil, 1997 (1997).
9. Maehr H. and Uskokovic M.R., Eur: J. Org. Chem., 1703 (2004).
10. Yong W., Ling S., Dhalleweyn C., Van Haver D., DeClercq P. and Vandewalle M., Bioorg. Med Chem. Lett, 7, 923 (1997).
11. Kutner A., Zhao H., Fitak H. and Wilson S.R., Bioorganic Chem., 23, 22 (1995).
12. Gabriels S., Van Haver D., Vandewalle M., Clercq P. De, Verstuyf A. and Bouillon R., Chem. -Eur: . 7, 520 (2001).
13. Biellmann J.F., Chem. Rev., 103, 2019 (2003).
14. Ariens E.J., Trends Pharmacol. Sci, 7, 200 (1986).
15. Buzby G.C., Hartley D., Hughes G.A. and Smith H., J Med. Chem., 10, 199 (1967).
16. Boyd A., Groen M.B., Hindriksen B., Marshall R..I., Sleigh T., lhrmslow E. and Zeelen F.J., Steroids, 4 615 (1982).
17.Westover E.J., Covey D.F., Brockman H.L., Brown R.E. and Pike L.J., J. Biol. Chem., 278, 5111 (2003).
18.Achmatowicz B., Gorobets E., Marczak S., Przezdziecka A., Steinmeyer A., Wicha J. and Zugel U., Tetrahedron Lett., 42, 2891 (2001).
19. Gorobets B., Stepanenko V. and Wicha J., Eur. J. Org Chem., 783 (2004).
20.Zhu G.-D. and Okamura W.H., Chem. Rev., 95, 1877 (1995).
21. Dai H. and Posner G.H., Synthesis, 1383 (1994).
22. Hanazawa T., Koyama A., Wada T., Morishige E., Okamoto S. and Sato F., Org. Lett., 5, 3 167 (2003).
23. Hiyarnizu H1., Ooi H., Inomoto Y., Bsumi T., Iwabuchi Y. and Hatakeyama S., Org. Lett. , 3, 473 (2001).
24. Konno K., Maki S., Fujishima T., Liu Z.P., Miura D., Chokki M. and Takayama H., Bioorg. Med. Chem. Lett., 8, 2817 (1998).
25. Fujishima T., Konno K., Nakagawa K., Kurobe M., Okano T. and Takayama H., Bioorg. Med. Chem., 123 (2000).
26. Achmatowicz B., Jankowski P. and Wicha J., Tetrahedron Lett., 37, 5589 (1996).
27. Paaren H.E., DeLuca H.F. and Schnoes H.K., J. Org. Chem., 45, 3253 (1980).
28. Toh H.T. and Okamura W.H., J Org. Chem., 48, 1414 (1983).
29. Wang Y., Ting H.-S., Huang I.-J., Chow Y.-C. and Huang Y.-T., Acta Chim. Sin., 24, 126 (1958).
30.Mitsunobu O., .Synthesis, 1 (1981).
31. Sammakia T. and Jacobs J.S., Tetrahedron Lett., 40, 2685 (1999).
32. Tahara Y., in U. S. Patent 5,283,345 (1994, Application May 6, 1992).
33. Blakemore P.R., Kocienski P.J., Marcmk S. and Wicha J ., Synthesis, 1209 (1999).
34. Luche J.-L., Rodriguez-Hahn L. and Crabbe P., J. Chem. Soc. Chem. Commun., 601 (1978).
35. Diaz M., Ferrero M., Fernandez S. and Gotor V., Tetrahedron Lett., 41, 775 (2000).
36.Dess D.B. and Martin J.C., J. Org. Chem., 48, 4155 (1983).
37. Julia M. and Paris I.-M., Tetrahedron Lett., 4833 (1973).
38. Kocienski P.J., Lythgoe B. and Ruston S., J. Chem. Soc., Perkin Trans. 1, 1290 (1979).
39. Blakemore P.R., Grzywacz P., Kocienski P. ., Marczak S. and Wicha J.,PoIish.J Chem. , 73, 1209 (1999)
40. Baggiolini E.G., Iacobelli J.A., Hennessy B.M., Batcho A.D., Sereno J .F. and Uskokovic M. J Org. Chem., 51, 3098 (1986).

Typ dokumentu

Bibliografia

Identyfikator YADDA

bwmeta1.element.baztech-article-BUJ3-0002-0012